Advanced

R&D and financial systems: the determinants of R&D expenditures in the Swedish pharmaceutical industry

Malmberg, Claes LU (2008) DRUID 25th Celebration Conference, 2008 In DRUID 25th Celebration Conference 2008 Proceedings
Abstract
This study investigates the determinants of R&D expenditures in the Swedish pharmaceutical industry from the 1960s to the mid 1990s. Various proxies for the rate of return of R&D (e.g. expected profit, sales and R&D productivity) as well as the availability of internal funding (proxied by past cash flows) have been used as explanatory variables in time series regressions. Past cash flow comes out as significant in regressions both at industry level and at firm level (made for each of the two largest companies). Another factor that is significant in most cases is expected sales. However, productivity of the R&D process does not seem to influence R&D expenditures. A comparison of these conclusions with studies of the... (More)
This study investigates the determinants of R&D expenditures in the Swedish pharmaceutical industry from the 1960s to the mid 1990s. Various proxies for the rate of return of R&D (e.g. expected profit, sales and R&D productivity) as well as the availability of internal funding (proxied by past cash flows) have been used as explanatory variables in time series regressions. Past cash flow comes out as significant in regressions both at industry level and at firm level (made for each of the two largest companies). Another factor that is significant in most cases is expected sales. However, productivity of the R&D process does not seem to influence R&D expenditures. A comparison of these conclusions with studies of the pharmaceutical industries in countries with different financial systems; the US (with a market based financial system) and Japan (with a more bank based financial system) shows that Sweden (also leaning towards a bank based financial system) has the insensitivity to R&D productivity in common with Japan. This may be interpreted as these industries’ are taking a ‘longer term view’ on their research than the US’. The sensitivity to cash flow, however, is possibly more pronounced in Sweden than in Japan and suggests an important role of internal financing of R&D. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Chapter in Book/Report/Conference proceeding
publication status
published
subject
keywords
Economic Development, Technological Change, Technological Growth, Innovation and Invention, Processes and Incentives, Government Policy, Economic History, Agriculture, Natural Resources
in
DRUID 25th Celebration Conference 2008 Proceedings
publisher
DRUID Denmark
conference name
DRUID 25th Celebration Conference, 2008
language
English
LU publication?
yes
id
b705dca5-c0f1-4d30-9a79-7299f6b3b1fa (old id 1411807)
alternative location
http://www2.druid.dk/conferences/viewabstract.php?id=2999&cf=29
date added to LUP
2009-06-17 12:57:59
date last changed
2016-10-07 15:24:13
@inproceedings{b705dca5-c0f1-4d30-9a79-7299f6b3b1fa,
  abstract     = {This study investigates the determinants of R&D expenditures in the Swedish pharmaceutical industry from the 1960s to the mid 1990s. Various proxies for the rate of return of R&D (e.g. expected profit, sales and R&D productivity) as well as the availability of internal funding (proxied by past cash flows) have been used as explanatory variables in time series regressions. Past cash flow comes out as significant in regressions both at industry level and at firm level (made for each of the two largest companies). Another factor that is significant in most cases is expected sales. However, productivity of the R&D process does not seem to influence R&D expenditures. A comparison of these conclusions with studies of the pharmaceutical industries in countries with different financial systems; the US (with a market based financial system) and Japan (with a more bank based financial system) shows that Sweden (also leaning towards a bank based financial system) has the insensitivity to R&D productivity in common with Japan. This may be interpreted as these industries’ are taking a ‘longer term view’ on their research than the US’. The sensitivity to cash flow, however, is possibly more pronounced in Sweden than in Japan and suggests an important role of internal financing of R&D.},
  author       = {Malmberg, Claes},
  booktitle    = {DRUID 25th Celebration Conference 2008 Proceedings},
  keyword      = {Economic Development,Technological Change,Technological Growth,Innovation and Invention,Processes and Incentives,Government Policy,Economic History,Agriculture,Natural Resources},
  language     = {eng},
  publisher    = {DRUID Denmark},
  title        = {R&D and financial systems: the determinants of R&D expenditures in the Swedish pharmaceutical industry},
  year         = {2008},
}